-
公开(公告)号:US20230145782A1
公开(公告)日:2023-05-11
申请号:US17772948
申请日:2020-10-29
发明人: Kevan Shokat , Keelan Guiley
IPC分类号: C07D495/14 , C07D487/04 , C07D498/04 , C07D413/14 , C07J43/00 , C07D209/86 , C07D209/88 , C07D209/42 , C07D403/04
CPC分类号: C07D495/14 , C07D487/04 , C07D498/04 , C07D413/14 , C07J43/003 , C07D209/86 , C07D209/88 , C07D209/42 , C07D403/04
摘要: Described herein, inter alia, are p53 modulator compounds and methods of using the same. In an aspect is provided a p53 protein covalently bonded to a compound described herein. In an aspect is provided a pharmaceutical composition including a compound described herein and a pharmaceutically acceptable excipient. In an aspect is provided a method of treating cancer in a subject in need of such treatment, including administering to the subject an effective amount of a compound described herein.
-
公开(公告)号:US11692179B2
公开(公告)日:2023-07-04
申请号:US16977441
申请日:2019-04-10
发明人: Seth Rubin , Keelan Guiley
CPC分类号: C12N9/12 , C07K14/4738 , C12Q1/485 , C12Y207/11022 , G01N2440/14 , G01N2500/02
摘要: The disclosure provides polypeptides comprising an engineered p27, or a fragment thereof. Such polypeptides may be used to form trimeric protein complexes with a cyclin-dependent kinase 4 (Cdk4) (or a variant thereof) or Cdk6 (or a variant thereof), and a cyclin D (CycD) or a variant thereof.
-